Trading Signals: CAPR Stock Price Prediction and Forecast (Tue. Apr. 1, 2003 - Fri. Jul. 2, 2021)(Capricor Therapeutics Inc)
| CAPR latest price $42.5000 (30.77%) ($32.5000 - $42.5000) on Wed. Oct. 16, 2013. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 10.33% (three month average) | RSI | 68 | Latest Price | $42.5000(30.77%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | CAPR advances 8.3% a day on average for past five trading days. | Weekly Trend | CAPR advances 10.5% a week on average for past two weeks. | Market Behavior | Normal for large cap. Normal for small cap. | Correlated ETFs | Broad market will support CAPR advance at 0% a week (0% probability) PEJ(5%) EWP(4%) IWM(4%) XAR(4%) XOP(4%) | Factors Impacting CAPR price | CAPR will decline at least -5.165% in a week (0% probabilities). IGOV(-2%) EMHY(-2%) REMX(-1%) GLD(-1%) EWY(-1%) | Explanation | The rally is not sustainable and not supported by the broad market. | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -5.165% (StdDev 10.33%) | Hourly BBV | 0 () | Intraday Trend | 13.3% | | | |
|
5 Day Moving Average | $32.6(30.37%) | 10 Day Moving Average | $30.95(37.32%) | 20 Day Moving Average | $28.58(48.71%) | To recent high | 0% | To recent low | 193.1% | Market Cap | $837m | | | | Capricor Therapeutics, Inc. engages in the discovery, development and commercialization of first-in-class biological therapies for the treatment of cardiac and other serious medical conditions. Its product candidate consists of CAP-1002, Cenderitide, Exosomes, CAP-1001, CU-NP and CSps. The company was founded in August 2005 and is headquartered in Beverly Hills, CA. |